In Reply

Affiliations

¹ Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota.
² Mayo Foundation for Medical Education and Research, Rochester, Minnesota.

Comment

Sean C Dowdy et al. Obstet Gynecol. 2017 Oct.

. 2017 Oct;130(4):914-915.

doi: 10.1097/AOG.0000000000002304.

¹ Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota.
² Mayo Foundation for Medical Education and Research, Rochester, Minnesota.

No abstract available

Comment on

Venous Thromboembolism: An Unrecognized Crisis in Gynecologic Oncology.
Lichten EM. Lichten EM. Obstet Gynecol. 2017 Oct;130(4):914. doi: 10.1097/AOG.0000000000002305. Obstet Gynecol. 2017. PMID: 28937561 No abstract available.

1. Xin G, Wei Z, Ji C, Zheng H, Gu J, Ma L, et al. Metformin uniquely prevents thrombosis by inhibiting platelet activation and mtDNA release. Sci Rep 2016;6:36222.
1. Kumar S, Meuter A, Thapa P, Langstraat C, Giri S, Chien J, et al. Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer 2013;119:555–62.
1. Sue-Ling HM, Davies JA, Prentice CR, Verheijen JH, Kluft C. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity. Thromb Haemost 1985;53:141–2.
1. Blamey SL, McArdle BM, Burns P, Carter DC, Lowe GD, Forbes CD. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery. Thromb Haemost 1984;51:71–4.
1. Lu DY, Huang CC, Huang PH, Chung CM, Lin SJ, Chen JW, et al. Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. BMC Cardiovasc Disord 2014;14:187.